ANDA 79074, held by Mylan Labs Ltd. Lopinavir; Ritonavir.
As of Nov 16, 2026, ANDA 79074 (Lopinavir And Ritonavir), held by Mylan Labs Ltd, was first approved by FDA on Feb 7, 2024, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 7, 2024 | Original application | Approved |
| Lopinavir And Ritonavir100MG;25MG · tablet;oral | Lopinavir; Ritonavir | Rx |
| Lopinavir And Ritonavir200MG;50MG · tablet;oral | Lopinavir; Ritonavir | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters